Luteolin is a bioflavonoid that attenuates adipocyte-derived inflammatory responses via suppression of nuclear factor-κB/mitogen-activated protein kinases pathway

BACKGROUND: Inflammation of adipocytes has been a therapeutic target for treatment of obesity and metabolic disorders which cause insulin resistance and hence lead to type II diabetes. Luteolin is a bioflavonoid with many beneficial properties such as antioxidant, antiproliferative, and anti-cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Nepali, Sarmila, Son, Ji-Seon, Poudel, Barun, Lee, Ji-Hyun, Lee, Young-Mi, Kim, Dae-Ki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522853/
https://www.ncbi.nlm.nih.gov/pubmed/26246742
http://dx.doi.org/10.4103/0973-1296.160470

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4522853/
https://www.ncbi.nlm.nih.gov/pubmed/26246742
http://dx.doi.org/10.4103/0973-1296.160470

Ejemplares similares